{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:07:51Z","timestamp":1765541271341,"version":"3.48.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Dementia Research Project through the Korea Dementia Research Center (KDRC) funded by the Korea government","award":["No. RS-2021-KH112636 and No. RS-2024-00337993"],"award-info":[{"award-number":["No. RS-2021-KH112636 and No. RS-2024-00337993"]}]},{"name":"National Research Council of Science and Technology (NST) Aging Convergence Research Center funded by the Korea government","award":["No. CRC22013-600"],"award-info":[{"award-number":["No. CRC22013-600"]}]},{"name":"Basic Science Research Program through the National Research Foundation of Korea funded by the Korea government","award":["No. NRF-2020M3E5D2A01084721"],"award-info":[{"award-number":["No. NRF-2020M3E5D2A01084721"]}]},{"name":"National Research Foundation of Korea grant funded by the Korea government","award":["No. 2023R1A2C2002925"],"award-info":[{"award-number":["No. 2023R1A2C2002925"]}]},{"name":"Institute of Information and Communications Technology Planning and Evaluation (IITP) funded by the Korea government","award":["No. 2022-0-00448\/RS-2022-II220448"],"award-info":[{"award-number":["No. 2022-0-00448\/RS-2022-II220448"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01907-3","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:52:03Z","timestamp":1765536723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polygenicity and APOE \u03b54 shape response to intervention in mild cognitive impairment"],"prefix":"10.1186","volume":"17","author":[{"given":"Jiyun","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaejin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Kyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hyung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwoo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae Ri","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joohon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Hye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"9984","key":"1907_CR1","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1907_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-024-01495-8","volume":"16","author":"K Deckers","year":"2024","unstructured":"Deckers K, Zwan MD, Soons LM, Waterink L, Beers S, van Houdt S, et al. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial. Alzheimers Res Ther. 2024;16(1):126.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1907_CR3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3233\/JAD-210331","volume":"82","author":"A Solomon","year":"2021","unstructured":"Solomon A, Handels R, Wimo A, Antikainen R, Laatikainen T, Levalahti E, et al. Effect of a multidomain lifestyle intervention on estimated dementia risk. J Alzheimers Dis. 2021;82(4):1461\u20136.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1907_CR4","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1002\/alz.14097","volume":"20","author":"AE Zulke","year":"2024","unstructured":"Zulke AE, Pabst A, Luppa M, Oey A, Weise S, Fankhanel T, et al. Effects of a multidomain intervention against cognitive decline on dementia risk profiles - results from the AgeWell.de trial. Alzheimers Dement. 2024;20(8):5684\u201394.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1907_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013;9(6):657\u201365.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"1907_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/alz.12123","volume":"16","author":"M Kivipelto","year":"2020","unstructured":"Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, et al. World-Wide FINGERS network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement. 2020;16(7):1078\u201394.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1907_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14283\/jpad.2019.41","volume":"7","author":"A Rosenberg","year":"2020","unstructured":"Rosenberg A, Mangialasche F, Ngandu T, Solomon A, Kivipelto M. Multidomain interventions to prevent cognitive impairment, Alzheimer\u2019s disease, and dementia: from FINGER to world-wide FINGERS. J Prev Alzheimers Dis. 2020;7(1):29\u201336.","journal-title":"J Prev Alzheimers Dis"},{"issue":"12","key":"1907_CR8","doi-asserted-by":"publisher","first-page":"15898","DOI":"10.18632\/aging.203213","volume":"13","author":"SY Moon","year":"2021","unstructured":"Moon SY, Hong CH, Jeong JH, Park YK, Na HR, Song HS, et al. Facility-based and home-based multidomain interventions including cognitive training, exercise, diet, vascular risk management, and motivation for older adults: a randomized controlled feasibility trial. Aging (Albany NY). 2021;13(12):15898\u2013916.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"1907_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3988\/jcn.2020.16.2.292","volume":"16","author":"HK Park","year":"2020","unstructured":"Park HK, Jeong JH, Moon SY, Park YK, Hong CH, Na HR, et al. South Korean study to prevent cognitive impairment and protect brain health through lifestyle intervention in at-risk elderly people: protocol of a multicenter, randomized controlled feasibility trial. J Clin Neurol. 2020;16(2):292\u2013303.","journal-title":"J Clin Neurol"},{"issue":"1","key":"1907_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12779\/dnd.2024.23.1.30","volume":"23","author":"SH Cho","year":"2024","unstructured":"Cho SH, Kang HJ, Park YK, Moon SY, Hong CH, Na HR, et al. South Korean study to prevent cognitive impairment and protect BRAIN health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): protocol for a multicenter randomized controlled trial. Dement Neurocogn Disord. 2024;23(1):30\u201343.","journal-title":"Dement Neurocogn Disord"},{"key":"1907_CR11","unstructured":"Moon SY, Park YK, Jeong JH, Hong CH, Jung J, Na HR, et al. South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trial. Alzheimers Dement. 2025;21(2):e14517."},{"issue":"10452","key":"1907_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selbaek G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572\u2013628.","journal-title":"Lancet"},{"issue":"4","key":"1907_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"1","key":"1907_CR14","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1038\/s41467-021-24082-z","volume":"12","author":"G Leonenko","year":"2021","unstructured":"Leonenko G, Baker E, Stevenson-Hoare J, Sierksma A, Fiers M, Williams J, et al. Identifying individuals with high risk of Alzheimer\u2019s disease using polygenic risk scores. Nat Commun. 2021;12(1):4506.","journal-title":"Nat Commun"},{"issue":"5","key":"1907_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1212\/WNL.0000000000002922","volume":"87","author":"EC Mormino","year":"2016","unstructured":"Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, et al. Polygenic risk of Alzheimer disease is associated with early-and late-life processes. Neurology. 2016;87(5):481\u20138.","journal-title":"Neurology"},{"issue":"Pt 12","key":"1907_CR16","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, et al. Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain. 2015;138(Pt 12):3673\u201384.","journal-title":"Brain"},{"issue":"11","key":"1907_CR17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jalz.2014.12.008","volume":"11","author":"HH Adams","year":"2015","unstructured":"Adams HH, de Bruijn RF, Hofman A, Uitterlinden AG, van Duijn CM, Vernooij MW, et al. Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia. Alzheimers Dement. 2015;11(11):1277\u201385.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1907_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41380-018-0030-8","volume":"24","author":"MW Logue","year":"2019","unstructured":"Logue MW, Panizzon MS, Elman JA, Gillespie NA, Hatton SN, Gustavson DE, et al. Use of an Alzheimer\u2019s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s. Mol Psychiatry. 2019;24(3):421\u201330.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1907_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13195-023-01298-3","volume":"15","author":"T Sofer","year":"2023","unstructured":"Sofer T, Kurniansyah N, Granot-Hershkovitz E, Goodman MO, Tarraf W, Broce I, et al. A polygenic risk score for Alzheimer\u2019s disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic\/Latino adults in the U.S. Alzheimers Res Ther. 2023;15(1):146.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"1907_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","volume":"17","author":"SJ van der Lee","year":"2018","unstructured":"van der Lee SJ, Wolters FJ, Ikram MK, Hofman A, Ikram MA, Amin N, et al. The effect of APOE and other common genetic variants on the onset of Alzheimer\u2019s disease and dementia: a community-based cohort study. Lancet Neurol. 2018;17(5):434\u201344.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1907_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13195-023-01277-8","volume":"15","author":"H Stocker","year":"2023","unstructured":"Stocker H, Trares K, Beyer L, Perna L, Rujescu D, Holleczek B, et al. Alzheimer\u2019s polygenic risk scores, APOE, Alzheimer\u2019s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. Alzheimers Res Ther. 2023;15(1):129.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1907_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40035-021-00259-w","volume":"10","author":"JM Pyun","year":"2021","unstructured":"Pyun JM, Park YH, Lee KJ, Kim S, Saykin AJ, Nho K, et al. Predictability of polygenic risk score for progression to dementia and its interaction with APOE epsilon4 in mild cognitive impairment. Transl Neurodegener. 2021;10(1):32.","journal-title":"Transl Neurodegener"},{"issue":"6","key":"1907_CR23","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1002\/alz.13843","volume":"20","author":"G Saadmaan","year":"2024","unstructured":"Saadmaan G, Dalmasso MC, Ramirez A, Hiltunen M, Kemppainen N, Lehtisalo J, et al. Alzheimer\u2019s disease genetic risk score and neuroimaging in the FINGER lifestyle trial. Alzheimers Dement. 2024;20(6):4345\u201350.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1907_CR24","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41598-018-37832-9","volume":"9","author":"S Moon","year":"2019","unstructured":"Moon S, Kim YJ, Han S, Hwang MY, Shin DM, Park MY, et al. The Korea Biobank array: design and identification of coding variants associated with blood biochemical traits. Sci Rep. 2019;9(1):1382.","journal-title":"Sci Rep"},{"key":"1907_CR25","unstructured":"Archive COD. Korean Imputation Service. Available from: http:\/\/150.183.251.152\/index.html#!"},{"issue":"3","key":"1907_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1907_CR27","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s41467-019-09718-5","volume":"10","author":"T Ge","year":"2019","unstructured":"Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10(1):1776.","journal-title":"Nat Commun"},{"issue":"5","key":"1907_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41588-022-01054-7","volume":"54","author":"Y Ruan","year":"2022","unstructured":"Ruan Y, Lin YF, Feng YA, Chen CY, Lam M, Guo Z, et al. Improving polygenic prediction in ancestrally diverse populations. Nat Genet. 2022;54(5):573\u201380.","journal-title":"Nat Genet"},{"issue":"1","key":"1907_CR29","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12(1):3417.","journal-title":"Nat Commun"},{"issue":"1","key":"1907_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41398-021-01272-3","volume":"11","author":"D Shigemizu","year":"2021","unstructured":"Shigemizu D, Mitsumori R, Akiyama S, Miyashita A, Morizono T, Higaki S, et al. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer\u2019s disease risk. Transl Psychiatry. 2021;11(1):151.","journal-title":"Transl Psychiatry"},{"issue":"9","key":"1907_CR31","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41596-020-0353-1","volume":"15","author":"SW Choi","year":"2020","unstructured":"Choi SW, Mak TS, O\u2019Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15(9):2759\u201372.","journal-title":"Nat Protoc"},{"issue":"4","key":"1907_CR32","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/ije\/dyx105","volume":"46","author":"Y Kim","year":"2017","unstructured":"Kim Y, Han BG, Ko GESG. Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2017;46(4):1350.","journal-title":"Int J Epidemiol."},{"issue":"12","key":"1907_CR33","doi-asserted-by":"publisher","first-page":"e2247162","DOI":"10.1001\/jamanetworkopen.2022.47162","volume":"5","author":"SH Jung","year":"2022","unstructured":"Jung SH, Kim HR, Chun MY, Jang H, Cho M, Kim B, et al. Transferability of Alzheimer disease polygenic risk score across populations and its association with Alzheimer disease-related phenotypes. JAMA Netw Open. 2022;5(12):e2247162.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1907_CR34","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.neuron.2025.02.017","volume":"113","author":"Z Li","year":"2025","unstructured":"Li Z, Martens YA, Ren Y, Jin Y, Sekiya H, Doss SV, et al. APOE genotype determines cell-type-specific pathological landscape of Alzheimer\u2019s disease. Neuron. 2025;113(9):1380\u201397 e7.","journal-title":"Neuron."},{"issue":"1","key":"1907_CR35","doi-asserted-by":"publisher","first-page":"e12226","DOI":"10.1002\/dad2.12226","volume":"13","author":"AJ Huq","year":"2021","unstructured":"Huq AJ, Fulton-Howard B, Riaz M, Laws S, Sebra R, Ryan J, et al. Polygenic score modifies risk for Alzheimer\u2019s disease in APOE epsilon4 homozygotes at phenotypic extremes. Alzheimers Dement (Amst). 2021;13(1):e12226.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1907_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13195-025-01764-0","volume":"17","author":"K Fujita","year":"2025","unstructured":"Fujita K, Kimura T, Yamakawa A, Niida S, Ozaki K, Sakurai T, et al. Genetic background and multidomain interventions in mild cognitive impairment. Alzheimers Res Ther. 2025;17(1):130.","journal-title":"Alzheimers Res Ther"},{"issue":"18","key":"1907_CR37","doi-asserted-by":"publisher","first-page":"e1605","DOI":"10.1212\/WNL.0000000000005415","volume":"90","author":"T Ge","year":"2018","unstructured":"Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino EC. Alzheimer\u2019s Disease Neuroimaging I. Dissociable influences of APOE epsilon4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. 2018;90(18):e1605\u201312.","journal-title":"Neurology."},{"key":"1907_CR38","doi-asserted-by":"crossref","unstructured":"Beydoun MA, Hu YH, Li Z, Georgescu MF, Beydoun HA, Noren Hooten N, et al. Alzheimer's disease polygenic risk's association with all-cause dementia through the plasma metabolome in the UK Biobank study. Geroscience. 2025;1\u201320.","DOI":"10.1007\/s11357-025-01724-4"},{"key":"1907_CR39","doi-asserted-by":"publisher","first-page":"849443","DOI":"10.3389\/fnagi.2022.849443","volume":"14","author":"Q Li","year":"2022","unstructured":"Li Q, Lv X, Jin F, Liao K, Gao L, Xu J. Associations of polygenic risk score for late-onset Alzheimer\u2019s disease with biomarkers. Front Aging Neurosci. 2022;14:849443.","journal-title":"Front Aging Neurosci"},{"issue":"237","key":"1907_CR40","first-page":"e5","volume":"84","author":"JA Elman","year":"2019","unstructured":"Elman JA, Panizzon MS, Logue MW, Gillespie NA, Neale MC, Reynolds CA, et al. Genetic risk for coronary heart disease alters the influence of Alzheimer\u2019s genetic risk on mild cognitive impairment. Neurobiol Aging. 2019;84(237):e5\u201312.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1907_CR41","doi-asserted-by":"publisher","first-page":"e70014","DOI":"10.1002\/alz.70014","volume":"21","author":"T D'Aoust","year":"2025","unstructured":"D\u2019Aoust T, Clocchiatti-Tuozzo S, Rivier CA, Mishra A, Hachiya T, Grenier-Boley B, et al. Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification. Alzheimers Dement. 2025;21(3):e70014.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1907_CR42","doi-asserted-by":"publisher","first-page":"11407","DOI":"10.1038\/s41598-025-95755-8","volume":"15","author":"CF Hernandez","year":"2025","unstructured":"Hernandez CF, Villaman C, Leu C, Lal D, Mata I, Klein AD, et al. Polygenic score analysis identifies distinct genetic risk profiles in Alzheimer\u2019s disease comorbidities. Sci Rep. 2025;15(1):11407.","journal-title":"Sci Rep"},{"issue":"1","key":"1907_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12877-019-1212-1","volume":"19","author":"A Zulke","year":"2019","unstructured":"Zulke A, Luck T, Pabst A, Hoffmann W, Thyrian JR, Gensichen J, et al. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients. BMC Geriatr. 2019;19(1):203.","journal-title":"BMC Geriatr"},{"issue":"10046","key":"1907_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","volume":"388","author":"EP Moll van Charante","year":"2016","unstructured":"Moll van Charante EP, Richard E, Eurelings LS, van Dalen JW, Ligthart SA, van Bussel EF, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet. 2016;388(10046):797\u2013805.","journal-title":"Lancet."},{"issue":"22","key":"1907_CR45","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","volume":"135","author":"P Natarajan","year":"2017","unstructured":"Natarajan P, Young R, Stitziel NO, Padmanabhan S, Baber U, Mehran R, et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation. 2017;135(22):2091\u2013101.","journal-title":"Circulation"},{"issue":"12","key":"1907_CR46","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamacardio.2024.3649","volume":"9","author":"ND Armstrong","year":"2024","unstructured":"Armstrong ND, Srinivasasainagendra V, Patki A, Jones AC, Parcha V, Pampana A, et al. Utility of a systolic blood pressure polygenic risk score with chlorthalidone response. JAMA Cardiol. 2024;9(12):1134\u201341.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"1907_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/alz.13515","volume":"20","author":"Y Xu","year":"2024","unstructured":"Xu Y, Sun Z, Jonaitis E, Deming Y, Lu Q, Johnson SC, et al. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer\u2019s disease and aging on preclinical cognitive function. Alzheimers Dement. 2024;20(2):1063\u201375.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1907_CR48","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"G Jun","year":"2010","unstructured":"Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol. 2010;67(12):1473\u201384.","journal-title":"Arch Neurol"},{"issue":"5 Suppl","key":"1907_CR49","first-page":"S269","volume":"10","author":"K Morgen","year":"2014","unstructured":"Morgen K, Ramirez A, Frolich L, Tost H, Plichta MM, Kolsch H, et al. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(5 Suppl):S269\u201376.","journal-title":"Alzheimers Dement"},{"key":"1907_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2020.09.014","volume":"99","author":"B Fulton-Howard","year":"2021","unstructured":"Fulton-Howard B, Goate AM, Adelson RP, Koppel J, Gordon ML, Alzheimer\u2019s Disease Genetics C, et al. Greater effect of polygenic risk score for Alzheimer\u2019s disease among younger cases who are apolipoprotein E-epsilon4 carriers. Neurobiol Aging. 2021;99:101 e1- e9.","journal-title":"Neurobiol Aging."},{"key":"1907_CR51","doi-asserted-by":"crossref","unstructured":"Xu Y, Sun Z, Jonaitis EM, Deming Y, Lu Q, Johnson SC, et al. Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals. medRxiv. 2024:2024.05. 26.24307953.","DOI":"10.1101\/2024.05.26.24307953"},{"key":"1907_CR52","doi-asserted-by":"crossref","unstructured":"Liu Y, Gu X, Li Y, Wang F, Vyas CM, Peng C, et al. Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function. Nat Med. 2025:1-11.","DOI":"10.1038\/s41591-025-03891-5"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01907-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01907-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01907-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:03:17Z","timestamp":1765540997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01907-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1907"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01907-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"type":"electronic","value":"1758-9193"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SUPERBRAIN-MEET study was conducted in accordance with the International Conference on Harmonization Good Clinical Practice (ICH-GCP) guidelines. The protocol was approved by the Inha University Hospital Institutional Review Board (IRB, approval No. INHAUH-2021\u201306-040) and by the IRBs of all participating centres, including the Ewha Womans University Seoul Hospital IRB (SEUMC-2021\u201307-037), the Ewha Womans University Mokdong Hospital IRB (EUMC-2021\u201308-003), the Ajou University Hospital IRB (AJIRB-BMR-SUR-21\u2013323), the Bobath Memorial Hospital IRB (P01-202109\u201311-002), the Dong-A University Hospital IRB (DAUHIRB-21\u2013168), the Chonnam National University Hospital IRB (CNUH-2021\u2013326), the Hanyang University Hospital IRB (HYUH-2021\u201307-041), the Myongji Hospital IRB (MJH-2021\u201308-032), the Jeonbuk National University Hospital IRB (CUH-2021\u201308-043), the Pusan National University Hospital IRB (2108\u2013016-015), the Konkuk University Hospital IRB (KUMC-2021\u201308-023), the Samsung Medical Center IRB (SMC-2021\u201308-022), the CHA Bundang Medical Center IRB (CHAMC-2022\u201301-020), the Catholic Kwandong University International St. Mary\u2019s Hospital IRB (IS22EIMI0008), the Daejeon Eulji Medical Center IRB (EMC-2021\u201312-004) and the Uijeongbu St. Mary\u2019s Hospital IRB (UIRB-2022\u20130428). Written informed consent was obtained from all participants prior to enrollment in the study. The trial was registered at ClinicalTrial.gov (NCT05023057) on 26 August 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SYM, CHH, JHJ, YKP, HRN, and SHC are shareholders of Rowan Inc. JJ reported being an employee of Rowan Inc. The remaining authors report no conflicts of Interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}